Genmab A/S (GMAB)
38.48
+3.73
(+10.73%)
USD |
NASDAQ |
Oct 05, 16:00
38.66
+0.18
(+0.47%)
After-Hours: 20:00
Genmab Max Drawdown (5Y) : 63.10% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 63.10% |
| August 31, 2026 | 63.10% |
| July 31, 2026 | 63.10% |
| June 30, 2026 | 63.10% |
| May 31, 2026 | 63.10% |
| April 30, 2026 | 63.10% |
| March 31, 2026 | 63.10% |
| February 28, 2026 | 63.10% |
| January 31, 2026 | 63.10% |
| December 31, 2025 | 63.10% |
| November 30, 2025 | 63.10% |
| October 31, 2025 | 63.10% |
| September 30, 2025 | 63.10% |
| August 31, 2025 | 63.10% |
| July 31, 2025 | 63.10% |
| June 30, 2025 | 63.10% |
| May 31, 2025 | 63.10% |
| April 30, 2025 | 63.10% |
| March 31, 2025 | 61.64% |
| February 28, 2025 | 61.64% |
| January 31, 2025 | 59.81% |
| December 31, 2024 | 58.91% |
| November 30, 2024 | 58.03% |
| October 31, 2024 | 54.19% |
| September 30, 2024 | 51.09% |
| Date | Value |
|---|---|
| August 31, 2024 | 48.99% |
| July 31, 2024 | 48.99% |
| June 30, 2024 | 48.42% |
| May 31, 2024 | 45.75% |
| April 30, 2024 | 45.75% |
| March 31, 2024 | 45.75% |
| February 29, 2024 | 45.75% |
| January 31, 2024 | 44.93% |
| December 31, 2023 | 44.93% |
| November 30, 2023 | 44.93% |
| October 31, 2023 | 44.93% |
| September 30, 2023 | 48.37% |
| August 31, 2023 | 48.37% |
| July 31, 2023 | 48.37% |
| June 30, 2023 | 48.37% |
| May 31, 2023 | 48.37% |
| April 30, 2023 | 48.37% |
| March 31, 2023 | 48.37% |
| February 28, 2023 | 48.37% |
| January 31, 2023 | 48.37% |
| December 31, 2022 | 48.37% |
| November 30, 2022 | 48.37% |
| October 31, 2022 | 48.37% |
| September 30, 2022 | 48.37% |
| August 31, 2022 | 48.37% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ascendis Pharma A/S | 61.72% |
| Zealand Pharma A/S | 74.12% |
| AbbVie, Inc. | 21.89% |
| Bavarian Nordic A/S | 74.23% |
| Evaxion AS | 99.79% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -15.91 |
| Beta (5Y) | 0.8145 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 34.63% |
| Historical Sharpe Ratio (5Y) | -0.2242 |
| Historical Sortino (5Y) | -0.4253 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 14.34% |